77 related articles for article (PubMed ID: 26886255)
41. Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state.
Roday S; Amukele T; Evans GB; Tyler PC; Furneaux RH; Schramm VL
Biochemistry; 2004 May; 43(17):4923-33. PubMed ID: 15109250
[TBL] [Abstract][Full Text] [Related]
42. Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases.
Lewandowicz A; Schramm VL
Biochemistry; 2004 Feb; 43(6):1458-68. PubMed ID: 14769022
[TBL] [Abstract][Full Text] [Related]
43. Use of 13C as an indirect tag in 15N specifically labeled nucleosides. Syntheses of [8-13C-1,7,NH2-15N3]adenosine, -guanosine, and their deoxy analogues.
Shallop AJ; Gaffney BL; Jones RA
J Org Chem; 2003 Oct; 68(22):8657-61. PubMed ID: 14575499
[TBL] [Abstract][Full Text] [Related]
44. Immunotoxin therapy of hematologic malignancies.
Frankel AE; Neville DM; Bugge TA; Kreitman RJ; Leppla SH
Semin Oncol; 2003 Aug; 30(4):545-57. PubMed ID: 12939723
[TBL] [Abstract][Full Text] [Related]
45. Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fcgamma receptor I-directed immunotoxin.
van Roon JA; van Vuuren AJ; Wijngaarden S; Jacobs KM; Bijlsma JW; Lafeber FP; Thepen T; van de Winkel JG
Arthritis Rheum; 2003 May; 48(5):1229-38. PubMed ID: 12746896
[TBL] [Abstract][Full Text] [Related]
46. Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases.
Sauve AA; Cahill SM; Zech SG; Basso LA; Lewandowicz A; Santos DS; Grubmeyer C; Evans GB; Furneaux RH; Tyler PC; McDermott A; Girvin ME; Schramm VL
Biochemistry; 2003 May; 42(19):5694-705. PubMed ID: 12741826
[TBL] [Abstract][Full Text] [Related]
47. Ribosome-inactivating proteins depurinate poly(ADP-ribosyl)ated poly(ADP-ribose) polymerase and have transforming activity for 3T3 fibroblasts.
Barbieri L; Brigotti M; Perocco P; Carnicelli D; Ciani M; Mercatali L; Stirpe F
FEBS Lett; 2003 Mar; 538(1-3):178-82. PubMed ID: 12633875
[TBL] [Abstract][Full Text] [Related]
48. Plant toxic proteins with insecticidal properties. A review on their potentialities as bioinsecticides.
Carlini CR; Grossi-de-Sá MF
Toxicon; 2002 Nov; 40(11):1515-39. PubMed ID: 12419503
[TBL] [Abstract][Full Text] [Related]
49. Isolation and enzymatic characterization of lamjapin, the first ribosome-inactivating protein from cryptogamic algal plant (Laminaria japonica A).
Liu RS; Yang JH; Liu WY
Eur J Biochem; 2002 Oct; 269(19):4746-52. PubMed ID: 12354105
[TBL] [Abstract][Full Text] [Related]
50. Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer.
Zang Z; Xu H; Yu L; Yang D; Xie S; Shi Y; Li Z; Li J; Wang J; Li M; Guo Y; Gu F
Chin Med J (Engl); 2000 Nov; 113(11):1002-6. PubMed ID: 11776112
[TBL] [Abstract][Full Text] [Related]
51. Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.
Miller DJ; Ravikumar K; Shen H; Suh JK; Kerwin SM; Robertus JD
J Med Chem; 2002 Jan; 45(1):90-8. PubMed ID: 11754581
[TBL] [Abstract][Full Text] [Related]
52. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.
Kanai T; Watanabe M; Okazawa A; Sato T; Yamazaki M; Okamoto S; Ishii H; Totsuka T; Iiyama R; Okamoto R; Ikeda M; Kurimoto M; Takeda K; Akira S; Hibi T
Gastroenterology; 2001 Oct; 121(4):875-88. PubMed ID: 11606501
[TBL] [Abstract][Full Text] [Related]
53. Adenine glycosylase activity in mammalian tissues: an equivalent of ribosome-inactivating proteins.
Barbieri L; Valbonesi P; Bondioli M; Alvarez ML; Dal Monte P; Landini MP; Stirpe F
FEBS Lett; 2001 Sep; 505(1):196-7. PubMed ID: 11557068
[No Abstract] [Full Text] [Related]
54. In vitro selection of RNA molecules that inhibit the activity of ricin A-chain.
Hesselberth JR; Miller D; Robertus J; Ellington AD
J Biol Chem; 2000 Feb; 275(7):4937-42. PubMed ID: 10671531
[TBL] [Abstract][Full Text] [Related]
55. Resolution of cutaneous inflammation after local elimination of macrophages.
Thepen T; van Vuuren AJ; Kiekens RC; Damen CA; Vooijs WC; van De Winkel JG
Nat Biotechnol; 2000 Jan; 18(1):48-51. PubMed ID: 10625390
[TBL] [Abstract][Full Text] [Related]
56. The two faces of the Escherichia coli 23 S rRNA sarcin/ricin domain: the structure at 1.11 A resolution.
Correll CC; Wool IG; Munishkin A
J Mol Biol; 1999 Sep; 292(2):275-87. PubMed ID: 10493875
[TBL] [Abstract][Full Text] [Related]
57. Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1.
Yu L; Gu F; Zhang C; Xie S; Guo Y
Chin Med J (Engl); 1998 May; 111(5):404-7. PubMed ID: 10374347
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24 month clinical results.
Clark DS; Emery JM; Munsell MF
J Cataract Refract Surg; 1998 Dec; 24(12):1614-20. PubMed ID: 9850900
[TBL] [Abstract][Full Text] [Related]
59. Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors.
Chen XY; Link TM; Schramm VL
Biochemistry; 1998 Aug; 37(33):11605-13. PubMed ID: 9708998
[TBL] [Abstract][Full Text] [Related]
60. Immunotoxins for brain tumor therapy.
Oldfield EH; Youle RJ
Curr Top Microbiol Immunol; 1998; 234():97-114. PubMed ID: 9670615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
